Ebola Outbreak in Congo Escalates to Record Levels

An Ebola outbreak in the Democratic Republic of Congo has surpassed 11,700 cases, marking the nation's deadliest occurrence as health workers struggle to contain the virus.
The Ebola outbreak centered in the Democratic Republic of Congo (DRC) has reached record levels, with confirmed cases surpassing 11,700 and the death toll exceeding 5,700 as of Nov. 19. The surge makes this the deadliest Ebola outbreak in the nation’s history and the second-deadliest worldwide. Despite ongoing efforts by health organizations to contain the virus, the disease has continued to spread, with confirmed cases reported in Uganda, Kenya, Nigeria, and France, as well as a patient treated in London.
Experts describe the rapid evolution of the outbreak as a “perfect storm” driven by a convergence of factors. Katie Thomas-Canfield, Ebola response director for the International Rescue Committee based in Bunia, attributes the fast spread to a combination of late detection, the specific strain of the virus, and humanitarian challenges. The outbreak is caused by the Bundibugyo strain, a rare variant for which no approved vaccine or targeted antiviral treatment currently exists. Unlike the more common Zaire strain, the Bundibugyo variant presents with symptoms that can easily be mistaken for other endemic illnesses, such as malaria, which often delays identification and treatment.
According to Dr. Abdou Sebushishe, a senior health adviser with the International Medical Corps, a significant surveillance gap occurred between the start of the outbreak in mid-to-late February and its formal detection by the World Health Organization (WHO) in mid-May. This delay allowed the initial transmission chain to go untracked, complicating efforts to monitor contacts as they moved across different locations.
Experts have also cited a decline in international humanitarian support as a contributing factor. The 2025 dismantling of the U.S. Agency for International Development (USAID) and funding cuts from other nations, including the U.K. and Germany, have constrained the global capacity to surveil, identify, and respond to emerging biomedical hazards. While many nations have increased funding in response to the current crisis, Thomas-Canfield noted that the erosion of long-term community surveillance and healthcare presence hindered the ability to intervene before the outbreak reached its current scale.
Containment efforts have been further impeded by community distrust and misinformation. In the first six months of the outbreak, the United Nations reported 260 attacks on health workers, fueled by rumors regarding isolation units and safe burial protocols that conflicted with local traditions. This resistance can exacerbate the spread of the virus, as affected individuals may seek care in informal settings rather than formal facilities. Furthermore, health officials report that security concerns can cause patients to flee while contagious, undermining containment measures.
Health experts emphasize that reinforcing primary and secondary health clinics with training and personal protective equipment is essential to catching cases earlier. Additionally, the WHO has cautioned against border closures, noting that they often force movement into informal, unscreened routes. Currently, the University of Oxford is developing a vaccine for the Bundibugyo strain, which is in clinical testing, while trials are also underway to determine if the Zaire-focused Ervebo vaccine offers any cross-protection. However, finalization of these trials remains pending, and health officials warn that the ultimate success of any vaccine will depend on the strength of community trust and engagement.